The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1275 articles
GLP-1 drugs like Ozempic promise dramatic weight loss, but what happens when you stop? Studies reveal rapid regain—often half or more of lost weight—due to rebound hunger and metabolic shifts. This guide breaks down the mechanisms, evidence, and sustainable strategies.
The MHRA has updated warnings for GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, highlighting a rare but serious risk of acute pancreatitis. With 1.6 million UK users in the past year, knowing the symptoms of severe abdominal pain radiating to the back is crucial. This guide breaks down the science, risks, and steps for safe use.
Wall Street tailors are busier than ever, altering suits for clients who've shed 20-30 pounds on Ozempic and similar GLP-1 drugs. This surge reflects the real-world impact of these medications, with studies showing up to 15% body weight loss. Explore the science behind it and how to maximize benefits safely.
Novo Nordisk's launch of an oral Wegovy pill marks a pivotal shift in GLP-1 therapy, offering a convenient alternative to injections for obesity treatment. This guide explores its mechanism, efficacy, safety profile, and how it stacks up against rivals like Eli Lilly's orforglipron. Learn what this means for your weight loss journey.
Ireland's HSE shelled out over €500k daily last year on GLP-1 injections like Ozempic and Saxenda for patients on free schemes. With usage surging 33% since 2023, explore the spending breakdown, regional variations, and what this means for access to these diabetes and weight loss treatments. Understand the science, eligibility, and future of drugs like Mounjaro.
GLP-1 medications like Ozempic and Wegovy are transforming weight management, but recent label updates highlight a small yet serious risk of acute pancreatitis. This guide breaks down the symptoms, science, and steps to stay safe. Know the signs to protect your health.
Emma lost 8 stone on Mounjaro but faced a life-threatening gallbladder crisis. Her story highlights rising GLP-1 side effects like gallstones amid surging UK surgeries. This guide unpacks the risks, science, and how to protect your health.
GLP-1 medications like Ozempic and Wegovy have transformed weight management, but reports of gastroparesis and bowel issues have sparked lawsuits. This guide breaks down the science, risks, and practical steps for patients. Learn how to balance benefits with safety through informed strategies.
Novo Nordisk's new Wegovy pill has exploded onto the scene, racking up over 26,000 prescriptions in just its second full week. This needle-free GLP-1 option signals a shift in obesity treatment. Discover the data, science, and patient implications behind this rapid uptake.
